Volume Alert - ACT 265.50 Actavis Inc $ACT Hit a high today

New Post Public Reply Private Reply Replies (0) Message Board
leahanne
Volume Alert - ACT 265.50 Actavis Inc $ACT Hit a high today of 267.20 Closing the day 10:30 at 265.50 -0.54 -0.20% With a day low of 264.45 and a total volume of 1,329,429.

ACT Recent Posts: http://investorshangout.com/Actavis-Inc-ACT-53105/

ACT Actavis Inc Recent Headline News

The Crucial Thing You're Missing About Many Dividend Stocks
Todd Campbell, The Motley Fool - Motley Fool - Thu Nov 20, 7:35AM CST
It's been proved time and time again that investing for the long haul is a better way to build wealth than short-term trading is. It's also been shown that dividend-paying stocks outperform their non-dividend-paying peers. When it comes down to...
ACT: 260.49 (-5.55), PFE: 30.38 (-0.06), AZN: 74.28 (-1.10), BMY: 58.58 (-0.23)

Tracking John Paulson's Paulson & Company Portfolio - Q3 2014 Update
John Vincent - at Seeking Alpha - Thu Nov 20, 12:49AM CST

RKT: 55.91 (+0.01), KOG: 10.08 (+0.32), MEAS: 86.00 (+0.01), HHC: 147.79 (+1.87), AET: 86.11 (+0.56), DLPH: 71.25 (+0.15), DLTR: 65.53 (+2.90), AEM: 26.75 (+0.70), AUXL: 33.16 (+0.13), DG: 66.89 (+0.79), ABBV: 65.38 (-0.12), DXM: 8.28 (+0.02), MNK: 86.72 (+0.74), ATHL: 58.40 (unch), NCQ: 0.69 (unch), COV: 97.35 (-0.15), AU: 9.39 (+0.05), MYL: 55.35 (-0.33), IAG: 2.26 (+0.05), FDO: 78.28 (-0.17), MGM: 22.30 (+0.11), GNW: 9.27 (+0.14), HIG: 40.82 (+0.02), NG: 2.87 (+0.07), EQIX: 221.80 (-3.88), HSH: 62.96 (unch), OAS: 26.44 (+0.59), PETM: 77.96 (-0.23), ACT: 260.43 (-5.61), MDT: 71.67 (-0.09), BPOP: 31.84 (-0.16), ENZY: 8.35 (-0.05), FCX: 28.36 (+0.28), GFI: 4.24 (+0.15), CZR: 15.10 (+0.73), CVC: 18.89 (-0.04), CIE: 10.73 (+0.60), CACQ: 10.30 (+0.11), AGN: 210.36 (-2.23), ECA: 18.08 (+0.28), FCH: 10.26 (+0.20), R: 90.90 (+0.35), DTV: 87.09 (-0.13), KMDA: 3.31 (-0.08), ANV: 1.67 (+0.18), MOVE: 20.95 (-0.03), BAC: 16.97 (-0.09), GRFS: 36.65 (+0.27), POST: 35.87 (+0.33), HCA: 67.67 (+0.63), RDN: 16.95 (+0.22), BEE: 13.00 (+0.06), CPWR: 10.28 (+0.12), GLD: 114.57 (+0.89), RLGY: 44.15 (+1.21), MTG: 9.30 (+0.33), HMHC: 20.00 (+0.06), CMCSA: 54.31 (-0.07), CBS: 53.66 (+0.32), BABA: 111.43 (+2.61)

Valeant Rises After Allergan Snub; Zeltiq In Buy Area
at Investor's Business Daily - Wed Nov 19, 5:14PM CST
Valeant Pharmaceuticals (VRX) hasn't missed a beat despite its failed takeover bid for Botox maker Allergan (AGN). Valeant lost out Monday to a competing bid from generic drugmaker Actavis (ACT), which said it would buy Allergan for $66 billion. Yet...
AGN: 210.36 (-2.23), ACT: 260.43 (-5.61), VRX: 142.57 (+0.10), ZLTQ: 28.52 (+0.40)

Mallinckrodt Q4 Earnings Beat Views, But Outlook Hazy
at Investor's Business Daily - Wed Nov 19, 4:35PM CST
Specialty drugmaker Mallinckrodt early Wednesday beat analysts' expectations handily with its fiscal Q4 report, but the stock fell 3.2% after the company put off providing hoped-for guidance in the wake of a Food and Drug Administration decision that...
MNK: 86.72 (+0.74), JNJ: 107.89 (-0.87), ACT: 260.43 (-5.61)

Celgene Up on Encouraging Long-Term Phase III Otezla Data - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Nov 19, 4:10PM CST
Celgene announced results from long-term efficacy and safety analyses from two phase III studies on Otezla.
ACT: 260.43 (-5.61), AMAG: 35.41 (+0.25), BMY: 58.58 (-0.23), CELG: 107.29 (+0.31)

Mallinckrodt Earnings Beat But No New Guidance
at Investor's Business Daily - Wed Nov 19, 10:42AM CST
Specialty drugmaker Mallinckrodt beat analysts' expectations handily in its fiscal Q4 report, but it didn't provide hoped-for guidance in the wake of an FDA decision that hits one of its best-selling drugs. Mallinckrodt (MNK) stock was down 4% in...
MNK: 86.72 (+0.74), JNJ: 107.89 (-0.87), ACT: 260.43 (-5.61), COV: 97.35 (-0.15)

Stock Market News for November 19, 2014 - Market News
Zacks Equity Research - Zacks Investment Research - Wed Nov 19, 9:10AM CST
Rally in healthcare stocks and easing global growth worries boosted benchmarks to finish in the green on Tuesday
URBN: 31.21 (+1.68), AGN: 210.36 (-2.23), HD: 97.67 (+0.97), ACT: 260.43 (-5.61), GILD: 101.68 (-0.66), PFE: 30.38 (-0.06), COV: 97.35 (-0.15), ALXN: 191.74 (-0.22)

Critical Alerts For Gold Fields, Actavis, Trina Solar Limited, Alcoa and Herbalife Released By InvestorsObserver
PR Newswire - Wed Nov 19, 8:31AM CST
InvestorsObserver issues critical PriceWatch Alerts for GFI, ACT, TSL, AA and HLF.
HLF: 39.39 (+0.73), AA: 17.09 (+0.40), ACT: 260.43 (-5.61), GFI: 4.24 (+0.15), TSL: 10.44 (-0.06)

Cramer's Mad Money - PPG Industries Will Blow Right Through Its All-Time High (11/18/14)
SA Editor Miriam Metzinger - at Seeking Alpha - Wed Nov 19, 4:30AM CST
Stocks discussed on the in-depth session of Jim Cramer's Mad Money TV Program, Tuesday November 18. CEO Interview: Chuck Bunch, PPG Industries (NYSE: PPG ) PPG Industries ( PPG ) has been a consistent performer. It has dominance in the...
AGN: 210.36 (-2.23), GPRO: 73.17 (-5.92), HD: 97.67 (+0.97), ACT: 260.43 (-5.61), BX: 32.94 (+0.27), S: 4.78 (+0.07), HAL: 49.00 (+0.57), M: 63.44 (+1.47), COP: 72.66 (+0.53), GPS: 40.12 (+0.58), BRK.B: 145.66 (+0.01), PPG: 212.19 (+1.53), BHI: 64.10 (+0.59)

Pharma Industry Outlook: M&A, Licensing Abound - Industry Outlook
Arpita Dutt - Zacks Investment Research - Wed Nov 19, 12:00AM CST
Pharma Industry Outlook: M&A, Licensing Abound - Industry Outlook
ACT: 260.43 (-5.61), QLTI: 3.92 (-0.07), VRX: 142.57 (+0.10), AGN: 210.36 (-2.23), SHPG: 211.36 (+3.78), AUXL: 33.16 (+0.13), ABBV: 65.38 (-0.12), SNY: 47.00 (-1.09), ABT: 43.52 (+0.09), ENDP: 69.52 (+0.51), AKRX: 37.87 (-0.31), PFE: 30.38 (-0.06), INCY: 71.29 (-0.01), SLXP: 103.71 (+0.08), MYL: 55.35 (-0.33), AMGN: 164.36 (+1.72), LLY: 66.84 (-0.37), GSK: 46.44 (+0.19), BMY: 58.58 (-0.23), ACHN: 13.37 (+0.46), MRK: 59.22 (-0.42), AZN: 74.28 (-1.10), ICPT: 156.50 (+0.57), TEVA: 57.21 (-0.04), NVS: 95.38 (-0.35)

Pharma Industry Outlook: M&A, Licensing Abound - Zacks Analyst Interviews
Arpita Dutt - Zacks Investment Research - Wed Nov 19, 12:00AM CST
Pharma Industry Outlook: M&A, Licensing Abound - Zacks Analyst Interviews
ACT: 260.43 (-5.61), QLTI: 3.92 (-0.07), VRX: 142.57 (+0.10), AGN: 210.36 (-2.23), SHPG: 211.36 (+3.78), AUXL: 33.16 (+0.13), ABBV: 65.38 (-0.12), SNY: 47.00 (-1.09), ABT: 43.52 (+0.09), ENDP: 69.52 (+0.51), AKRX: 37.87 (-0.31), PFE: 30.38 (-0.06), INCY: 71.29 (-0.01), SLXP: 103.71 (+0.08), MYL: 55.35 (-0.33), AMGN: 164.36 (+1.72), LLY: 66.84 (-0.37), GSK: 46.44 (+0.19), BMY: 58.58 (-0.23), ACHN: 13.37 (+0.46), MRK: 59.23 (-0.41), AZN: 74.28 (-1.10), ICPT: 156.50 (+0.57), TEVA: 57.21 (-0.04), NVS: 95.38 (-0.35)

Pharma ETFs In Focus On Allergan Takeover Deal
Zacks Funds - at Seeking Alpha - Tue Nov 18, 9:04PM CST
The healthcare space is witnessing 2014 as another banner year thanks to encouraging industry trends, solid corporate earnings and huge levels of merger and acquisition activities. The sector is clearly leading the broad market rally and this trend...
IHE: 147.53 (+0.01), AGN: 210.36 (-2.23), PPH: 64.98 (-0.37), ACT: 260.43 (-5.61), XPH: 110.54 (+0.21)

Jim Cramer's 'Mad Money' Recap: Why Running With the Bulls Is Profitable but Dangerous
at The Street - Tue Nov 18, 7:10PM CST
It's hard to be skeptical about high-flying stocks when the bulls are making money right now, Cramer says.
MMM: 159.43 (+0.60), AMZN: 330.09 (+3.55), JEC: 48.86 (+1.66), ACT: 260.43 (-5.61), HD: 97.65 (+0.95), BX: 32.94 (+0.27), DPLO: 25.02 (+0.52), UNH: 96.70 (-0.16), DECK: 95.86 (+1.34), COLM: 43.40 (-0.27), ALKS: 55.05 (+0.79), ADT: 35.61 (+0.24), CELG: 107.28 (+0.30), VE: 17.76 (-0.29), URBN: 31.21 (+1.68), AGN: 210.36 (-2.23), HLT: 25.38 (-0.14), AA: 17.09 (+0.40), RIG: 25.54 (+0.18), WMB: 55.41 (+0.19), PF: 32.98 (+0.08), PPG: 212.19 (+1.53), WPZ: 53.89 (+0.77)

Actavis'
at Investor's Business Daily - Tue Nov 18, 5:42PM CST
Actavis' (ACT) $66 bil takeover of Allergan (AGN) gets activist investor William Ackman's support, said Reuters. Ackman will reportedly withdraw a special shareholder meeting request at Allergan. Actavis shares jumped 8.7% to 269.60. Allergan rose 2%...
AGN: 210.36 (-2.23), ACT: 260.43 (-5.61)

Celldex Therapeutics Surges on Positive Rindopepimut Data - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Nov 18, 4:05PM CST
Celldex Therapeutics announced encouraging interim update from the phase II ReACT study evaluating the use of rindopepimut.
ACT: 260.43 (-5.61), CLDX: 20.93 (+2.20), ABBV: 65.38 (-0.12)

Vipshop, Jack in the Box Rise In After-Hours Trading
at Investor's Business Daily - Tue Nov 18, 4:04PM CST
Stocks finished higher Tuesday, with the Dow Jones industrial average and the S&P 500 making fresh all-time highs and the Nasdaq overcoming Monday's weakness with a 14 1/2-year high. Volume was higher than Monday on the NYSE and slightly lower on the...
AGN: 210.36 (-2.23), JACK: 75.10 (+0.18), ACT: 260.43 (-5.61), VIPS: 22.76 (+0.32)

Market News: Actavis Plc, SunEdison Inc, Halliburton Company
at The Street - Tue Nov 18, 3:54PM CST
Investors' confidence on the U.S. economy increased due to better-than-expected corporate earnings and economic data The stock markets in the United States rallied amid investors' speculation that...
ACT: 260.43 (-5.61), TERP: 31.86 (-0.06), SUNE: 22.05 (+0.52), HAL: 49.00 (+0.57), BHI: 64.10 (+0.59)

Stocks Hit New Milestones; BitAuto Rebounds
at Investor's Business Daily - Tue Nov 18, 3:17PM CST
Stocks reached new milestones Tuesday following a mixed performance in the prior session. The Nasdaq made back Monday's loss and then some as it rallied 0.7% to a 14-1/2-year high. The S&P 500 and the Dow Jones industrial average climbed 0.5% and...
AGN: 210.36 (-2.23), VRX: 142.57 (+0.10), ACT: 260.43 (-5.61), BITA: 87.31 (-0.82), BABA: 111.43 (+2.61)

Stock Market Today: Oil Slump Fuels S&P 500 to Fresh Record High
at The Street - Tue Nov 18, 3:09PM CST
Three cheers for the S&P 500 which closed the session at an all-time high for a fifth-consecutive session.
SPLS: 13.93 (+0.01), ACT: 260.43 (-5.61), HD: 97.66 (+0.96), MDT: 71.67 (-0.09), XOM: 95.40 (-0.21), AGN: 210.36 (-2.23), URBN: 31.21 (+1.68), TJX: 63.40 (+1.27), GILD: 101.67 (-0.67), TOT: 58.47 (-0.01), TGT: 71.42 (-1.08), LOW: 62.60 (+0.34), CVX: 116.60 (+0.13)

Zoetis 2015 Guidance Misses As Buyout Theories Abound
at Investor's Business Daily - Tue Nov 18, 2:15PM CST
Animal-health giant Zoetis (ZTS) offered 2015 guidance below the Street's consensus along with longer-term financial goals at its analyst day Tuesday. After a brief halt in trading for the early-afternoon announcement, the stock was down more than 1%...
AGN: 210.36 (-2.23), ZTS: 43.01 (-0.39), ABT: 43.52 (+0.09), ACT: 260.43 (-5.61), VRX: 142.57 (+0.10), PFE: 30.38 (-0.06)
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Wallstreet Sand Hands Its Massive Permian Plant to Wilbanks

Updated Category News Views 22

A sand plant can brag about acreage and horsepower all day, but frac crews remember who kept material arriving when a completion schedule got ugly. That is the real backdrop to PI Holdings and Wallstreet Sand Co. naming Blaine Wilbanks president of both businesses on November 18, 2026. This is not a ceremonial chair swap. Wallstreet has built an enormous Permian sand...

Continue Reading
Apani Adds Kelsun Assets to Its Natural Fiber Platform

Updated Category News Views 141

A materials deal with more chemistry than chest-thumping Seaweed and cotton have landed under one roof, which is a lot more interesting than another apparel brand slapping a green label on ordinary fabric. Apani said November 17 it acquired the assets of Keel Labs, bringing Keel's seaweed-based Kelsun fiber alongside Apani's enhanced cotton-cellulose filament technology....

Continue Reading
Linkind's Best Buy Push Tests Smart Outdoor Demand

Updated Category News Views 77

Holiday lights have quietly become a year-round hardware category, and Linkind wants a louder seat at the table. The smart-lighting brand says three outdoor products have been in Best Buy stores across the United States since October 17, 2026: permanent exterior lights, decorative string lights, and solar pathway lights. That is a real distribution step, not some grand...

Continue Reading
Dolby's Strong Quarter Meets a Flat 2027 Reality Check

Updated Category News Views 92

A licensing machine just coughed up a very good quarter, then told investors not to expect the engine to accelerate next year. That is the whole Dolby story in one uncomfortable breath. NYSE:DLB finished fiscal 2026 with fourth-quarter revenue of $374 million, up from $307 million a year earlier, while GAAP diluted earnings climbed to $0.86 from $0.51. Those are not...

Continue Reading
Novo and nference Push Whole-Body Data Into Research

Updated Category News Views 26

Cardiometabolic medicine has spent too long staring at single numbers while the rest of the body keeps waving its arms. Novo Nordisk’s newly announced collaboration with nference is an attempt to widen that lens, combining Novo’s clinical-trial research with nference’s AI technology and federated healthcare data network. The target is not small: obesity, diabetes,...

Continue Reading
Cold-Season Cleaning Advice Has a Practical Catch!

Updated Category News Views 11

Remote Controls Are Nobody’s First Suspect A television remote can make the rounds all evening and never see a cloth, which is precisely why Maid Brigade’s cold-and-flu-season reminder lands as common sense rather than revelation. The Scottsdale cleaning company is telling households to look past the usual kitchen counter and bathroom sink routine. Fair enough. People...

Continue Reading
Berlin Heals Puts Microcurrent Therapy to a Real Test

Updated Category News Views 26

A silent electrical signal is heading into the sort of trial that separates intriguing ideas from credible medical evidence. Berlin Heals Holding AG has initiated C-MIC IV, an international randomized, double-blind, sham-controlled study of its implanted microcurrent therapy for symptomatic heart failure. The first patient has already been implanted in Kragujevac, Serbia....

Continue Reading
Red Cat Stock Drama: Revenue Targets and Legal Waves

Updated Category News Views 183

Red Cat's Revenue Predictions Crash and Burn Sitting there on August 6, 2026, Red Cat Holdings had everyone believing they were on a fast track to hitting a hefty revenue target: $150–$180 million for FY2026. CEO Jeffrey Thompson didn't mince words, boasting confidence like a captain before a storm. Fast forward three months, and they're waving the white flag, tossing...

Continue Reading
Oracle Takes AI to Construction's Messy Project Middle

Updated Category News Views 57

A stalled drywall inspection can wreck a schedule faster than any glossy AI pitch can repair it. That is the grimy, practical corner Oracle is aiming at with its latest Oracle Primavera Cloud upgrades: the daily hunt for answers, the repeated logging of familiar risks, and the finger-pointing that starts when a milestone is suddenly in danger. This is not a chatbot being...

Continue Reading
Paratus on the Move: Seagems JV Under the Microscope

Updated Category News Views 239

What's Cooking with Paratus Energy? Paratus Energy Services Ltd. (ticker: PLSV) just threw us a curveball, announcing a strategic review of its participation in the Seagems joint venture. Now, before you get too jazzed about ticker talk—hold your horses. No one's making any promises about transactions just yet. The decision's still hanging in the balance, even as they...

Continue Reading

Top 5 Most Recently Viewed Articles

Laser Photonics CMS Expands Their Market Presence with New Orders

Updated Category News Views 145

Laser Photonics CMS Expands Their Market Presence with New Orders Laser Photonics Corporation (NASDAQ: LASE), a prominent global player in the manufacturing of innovative industrial laser systems, has announced recent progress from its subsidiary, Control Micro Systems (CMS). This exciting development highlights the increasing applications of laser technology in various...

Continue Reading
WuXi Biologics Expands Operations with New Syringe Production Line

Updated Category News Views 221

WuXi Biologics Expands Production Capabilities WuXi Biologics (2269.HK), a renowned global Contract Research, Development, and Manufacturing Organization (CRDMO), is set to strengthen its product capabilities by launching a new sterile filling line designed specifically for prefilled syringes (PFS). This initiative is taking place at WuXi's facility in Leverkusen,...

Continue Reading
Unlocking the Future: SEALSQ's MS6003 Secure Element Launch

Updated Category News Views 232

Revolutionizing Secure Authentication with MS6003 SEALSQ Corp (NASDAQ: LAES), a leader in semiconductor innovation, has recently announced a significant addition to its product portfolio: the MS6003 secure element chip. This state-of-the-art chip is equipped with a preloaded FIDO2 application, marking a pivotal step towards enhancing passwordless authentication in an era...

Continue Reading
Boeing's Outlook Brightens Amid Trade Deal Backlogs

Updated Category News Views 197

Boeing's Promising Trade Developments Boeing Co.'s earnings call showcased a significant shift in the global trade landscape, influenced by recent agreements during the Trump administration. This transition is likely to ease tariff pressures, providing vital support for the aerospace giant’s impressive backlog that currently exceeds $600 billion. The Financial Snapshot...

Continue Reading
Supreme Court's Decision on Appian vs. Pegasystems Verdict Case

Updated Category News Views 407

Supreme Court to Review Appian's Petition Against Pegasystems The Supreme Court of Virginia has decided to hear a significant legal case involving Appian and Pegasystems, Inc., which revolves around a staggering judgment amounting to $2.036 billion. This case is crucial as it pertains to the protection of intellectual property and trade secrets in the tech industry....

Continue Reading